loading page

Comment on: Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib
  • Paige Vicenzi,
  • Anish Ray
Paige Vicenzi

Corresponding Author:[email protected]

Author Profile
Anish Ray
Cook Children's Health Care System
Author Profile
06 Oct 2020Submitted to Pediatric Blood & Cancer
06 Oct 2020Assigned to Editor
06 Oct 2020Submission Checks Completed
07 Oct 2020Editorial Decision: Accept
21 Oct 2020Published in Pediatric Blood & Cancer. 10.1002/pbc.28776